Medtronic
Questions? Call our TAVR support team: 800-258-9220

Medtronic TAVR for women:

Treat your severe aortic stenosis†

Heart valve failure (severe aortic stenosis) has serious risks — and treating it can’t wait. Medtronic TAVR is proven for women.‡,1–3 Get help now, and imagine life in full color.

Healthcare professionals, visit WomenWithAS.com.

†Medtronic TAVR is indicated to treat patients who have been diagnosed with symptomatic severe aortic stenosis.
Older couple with dog
Left arrow
1
Left arrow

What symptoms5 are you experiencing?

Select all that apply.

Next

This is a required question

Please select an answer from the list above.
Left arrow
2

What is your age?


Please select an answer from the list above.
Female Medtronic TAVR patient

Sally

Medtronic TAVR patient

This is a required question

3

Have you ever been diagnosed with heart valve failure?

This is also known as symptomatic severe aortic stenosis, and it's OK if you're not sure.

This is a required question

Please select an answer from the list above.

Julia

Medtronic TAVR patient
Left arrow
4
Back arrow

Let’s take your next TAVR step, together.

Our Medtronic TAVR support team can help you find experienced heart team options in your area.

*Required fields

Medtronic will only use your data for marketing purposes related to relevant medical education. You may opt out at any time.
© Medtronic. US-CV-2600703 V3.0

Thank you for sharing!

A member of our Medtronic TAVR support team will reach out shortly to answer your questions and help you find experienced heart team options in your area.
Senior couple Medtronic TAVR patient

Thank you for sharing!

Medtronic TAVR is indicated to treat patients with symptomatic severe aortic stenosis. Talk to your doctor about testing and diagnosis. When you’re ready, we’re here to help.


Learn more about Medtronic TAVR

Senior couple Medtronic TAVR patient
Important Safety Information ⟶

Treating aortic stenosis can't wait


Severe aortic stenosis will not improve on its own. If left untreated, once severe symptoms develop, the average patient survival rate at two years is just 50%.4 Medtronic TAVR is helping women beat the odds.1

Find a heart team:

Locate a heart team for a simple evaluation

What is symptomatic severe aortic stenosis?

Severe aortic stenosis, also known as heart valve failure, is a progressive condition that prevents your aortic valve from opening and closing properly. The only effective treatments for severe aortic stenosis are valve replacement procedures.5

What are symptoms of severe aortic stenosis?

Symptoms can include shortness of breath, chest tightness, dizziness, feeling faint, or fatigue.5 Because these can also be mistaken for normal aging, it’s important to talk to your doctor.

What is transcatheter aortic valve replacement (TAVR)?

TAVR is a minimally invasive procedure to replace the aortic valve. Typically, it takes one hour, and patients are discharged within a day or two.
Severe aortic stenosis, also known as heart valve failure, is a progressive condition that prevents your aortic valve from opening and closing properly. The only effective treatments for severe aortic stenosis are valve replacement procedures.5
Symptoms can include shortness of breath, chest tightness, dizziness, feeling faint, or fatigue.5 Because these can also be mistaken for normal aging, it’s important to talk to your doctor.
TAVR is a minimally invasive procedure to replace the aortic valve. Typically, it takes one hour, and patients are discharged within a day or two.

See how Medtronic TAVR can transform women’s lives1


From diagnosis to recovery, hear from Darian, a patient who regained a sense of independence after her TAVR procedure.

Is TAVR for you? Find out.

Please talk to your doctor to decide whether this therapy is right for you.
Benefits may vary, for some patients, the Medtronic TAVR procedure risks may outweigh the benefits. TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.

Medtronic TAVR:

Proven for women‡,1–3


In a first-of-its-kind study of patients with small heart valves — nearly all of them women — the Medtronic Evolut™ TAVR valve delivered excellent valve performance§ compared to the Edwards SAPIEN™* TAVR valve, with equal safety results at two years.

Results from the SMART clinical trial at two years:

better valve function icon4X

better valve function compared to Edwards TAVR§,1

better blood flow icon10X

better blood flow compared to Edwards TAVR◊,1

Questions? Call 800-258-9220

TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.

FAQ: TAVR questions answered


Is TAVR for you? Find out.

How do I know if TAVR is right for me?

TAVR may be a good option for you if you are having symptoms and if tests performed by your heart team show that it may be helpful. TAVR may also be an option for you if you are at risk for open-heart surgery. Find out.

What is a TAVR procedure like?

TAVR is less invasive than open-heart surgery, also known as surgical aortic valve replacement (SAVR), and after pre-op, the procedure typically takes less than one hour. Your heart team will determine if you should have a mild sedative or general anesthesia.

What is recovery from TAVR like?

After the procedure, most patients spend a few hours in the intensive care unit before transferring to a patient room. Typically, patients begin walking the same day as their Medtronic TAVR procedure and are discharged within a day or two.

What is the difference between TAVR and open-heart surgery?

TAVR is less invasive than open-heart surgery (SAVR). Patients experience shorter hospital stays and have a faster return to normal activities with TAVR.6

TAVR may be a good option for you if you are having symptoms and if tests performed by your heart team show that it may be helpful. TAVR may also be an option for you if you are at risk for open-heart surgery. Find out.
TAVR is less invasive than open-heart surgery, also known as surgical aortic valve replacement (SAVR), and after pre-op, the procedure typically takes less than one hour. Your heart team will determine if you should have a mild sedative or general anesthesia.
After the procedure, most patients spend a few hours in the intensive care unit before transferring to a patient room. Typically, patients begin walking the same day as their Medtronic TAVR procedure and are discharged within a day or two.
TAVR is less invasive than open-heart surgery (SAVR). Patients experience shorter hospital stays and have a faster return to normal activities with TAVR.6

If you have more questions, click here.

Is TAVR for you? Find out.
TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker. Talk to your doctor about the risks and benefits of a TAVR procedure.

Medtronic TAVR:

Life in full color starts here.1


A heart valve failure diagnosis is too serious to delay treatment. Talk with the Medtronic TAVR support team to learn more about treatment, get answers to questions, and get help locating heart team options.

Selection icon

Is TAVR right for you?

Find out

Location icon

Find a heart team

Phone icon

Talk to our TAVR support team

Call us: 800-258-9220

† Medtronic TAVR is indicated to treat patients who have been diagnosed with symptomatic severe aortic stenosis.

‡ Based on the 2-year follow-up results from the SMART clinical trial, which demonstrated differences in valve performance‡ for Evolut compared with SAPIEN* and no differences in safety outcomes. SMART primarily enrolled patients with small annuli, the majority of whom were women.¹ Additional clinical trials evaluating women across a range of annulus sizes have shown lower mortality at 1 year for women treated with TAVR compared with surgical valve replacement,² with comparable mortality through 5 years in a separate study.³

§ Valve performance is as defined as freedom from bioprosthetic valve dysfunction (BVD) through 24 months. BVD is defined as a composite including any of the following: hemodynamic structural valve dysfunction (mean gradient ≥ 20 mmHg), non-structural valve dysfunction (severe prothesis-patient mismatch or ≥ moderate aortic regurgitation), clinical thrombosis, endocarditis, and aortic valve reintervention.

◊ Better blood flow, or "near-normal transvalvular flow," means that your new heart is operating well and the gradient across your valve is < 20 mmHg.


  1. Bleiziffer S, on behalf of SMART Trial Investigators. Two-year outcomes for Women in the Five-year SMART Trial. Presented at AHA 2025; November 8, 2025; New Orleans, USA.
  2. Skelding, K.A., et al., Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial). Am J Cardiol, 2016;118(4): 560-6.
  3. Wykrzykowska, J. Sex-specific Outcomes at 5 Years in the Evolut Low Risk Trial. Presented at PCR London Valves 2025; November 17, 2025; London, UK.
  4. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. July 1968;38(1 Suppl):61-67.
  5. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. February 2, 2021;143(5):e35-e71.
  6. Popma, J.J., et al., Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med, 2019. 380(18):p. 1706-1715.